---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-054784"
form_type: "8-K"
ticker: "OPRX"
cik: "0001448431"
company_name: "OptimizeRx Corp"
filed_at: "2025-06-16T23:59:59+00:00"
generated_at: "2026-05-19T06:16:13.089294+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# OptimizeRx stockholders elect five directors, approve say-on-pay at 2025 annual meeting

## Summary
- All five director nominees elected; Catherine Klema received most votes (11,050,447 for).
- Advisory say-on-pay approved with 5,443,720 in favor vs 3,857,653 against and 3,757,636 abstentions.
- Ratification of UHY LLP as auditor approved with 15,162,244 votes for.
- Total shares outstanding 18,493,447; broker non-votes of 2,874,955 on director and say-on-pay proposals.

## SEC filing metadata
- accession: 0001213900-25-054784
- form_type: 8-K
- ticker: OPRX
- cik: 0001448431
- company_name: OptimizeRx Corp
- filed_at: 2025-06-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1448431/000121390025054784/0001213900-25-054784-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1448431/000121390025054784/ea0245924-8k_optimize.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-054784
- JSON: https://secwatch.observer/filing/0001213900-25-054784.json
- Plain text: https://secwatch.observer/filing/0001213900-25-054784.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
